![AbbVie Appoints Robert A. Michael as CEO](https://i-invdn-com.investing.com/news/World_News_8_150x108_S_1420026210.jpg)
Please try another search
Period Ending: | Mar 31, 2024 | Dec 31, 2023 | Jun 30, 2023 | Mar 31, 2023 |
---|---|---|---|---|
Total Revenue | 495.02 | 576.47 | 560.02 | 522.1 |
Gross Profit | 16.46 | 33.12 | 21.37 | 35.65 |
Operating Income | -30.91 | -21.4 | -25.26 | -10.03 |
Net Income | -24.69 | -14.94 | -8.39 | 9.64 |
Period Ending: | Mar 31, 2024 | Dec 31, 2023 | Jun 30, 2023 | Mar 31, 2023 |
---|---|---|---|---|
Total Assets | 3945.53 | 4070.57 | 3640.62 | 3627.25 |
Total Liabilities | 1109.1 | 1209.45 | 749.62 | 709.93 |
Total Equity | 2836.42 | 2891 | 2917.31 |
Period Ending: | Mar 31, 2024 | Dec 31, 2023 | Jun 30, 2023 | Mar 31, 2023 |
---|---|---|---|---|
Period Length: | 0 Months | 0 Months | 0 Months | 0 Months |
Cash From Operating Activities | -125.02 | 53.05 | 67.81 | -65.34 |
Cash From Investing Activities | -142.7 | -106.48 | -36.05 | -152.04 |
Cash From Financing Activities | 44.79 | 57.12 | -6.75 | -27.21 |
Net Change in Cash | -223.03 | 3.74 | 25.69 | -244.98 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review